6,614 Shares in Bruker Co. (NASDAQ:BRKR) Bought by Vontobel Holding Ltd.

Vontobel Holding Ltd. acquired a new position in shares of Bruker Co. (NASDAQ:BRKR) in the fourth quarter, Holdings Channel reports. The firm acquired 6,614 shares of the medical research company’s stock, valued at approximately $388,000.

A number of other hedge funds have also recently made changes to their positions in the stock. FMR LLC raised its stake in Bruker by 21.4% in the third quarter. FMR LLC now owns 14,306,122 shares of the medical research company’s stock valued at $987,981,000 after buying an additional 2,521,904 shares during the last quarter. Vaughan Nelson Investment Management L.P. raised its stake in Bruker by 140.3% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 1,141,762 shares of the medical research company’s stock valued at $66,930,000 after buying an additional 666,617 shares during the last quarter. Point72 DIFC Ltd increased its holdings in shares of Bruker by 4,875.9% in the third quarter. Point72 DIFC Ltd now owns 470,171 shares of the medical research company’s stock valued at $32,470,000 after purchasing an additional 460,722 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Bruker by 1,933.2% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 410,234 shares of the medical research company’s stock valued at $28,331,000 after purchasing an additional 390,057 shares during the period. Finally, State Street Corp increased its holdings in shares of Bruker by 9.6% in the third quarter. State Street Corp now owns 3,627,300 shares of the medical research company’s stock valued at $250,501,000 after purchasing an additional 318,808 shares during the period. 79.52% of the stock is currently owned by hedge funds and other institutional investors.

Bruker Stock Performance

BRKR opened at $52.92 on Friday. The stock has a market cap of $8.02 billion, a P/E ratio of 69.63, a P/E/G ratio of 2.07 and a beta of 1.16. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 0.77. The stock’s 50 day simple moving average is $56.87 and its 200 day simple moving average is $60.13. Bruker Co. has a 1-year low of $48.07 and a 1-year high of $94.86.

Bruker (NASDAQ:BRKR) last posted its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. As a group, equities analysts anticipate that Bruker Co. will post 2.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on BRKR. Citigroup cut their price objective on Bruker from $80.00 to $75.00 and set a “buy” rating on the stock in a report on Wednesday, November 6th. Bank of America increased their price objective on Bruker from $78.00 to $80.00 and gave the company a “buy” rating in a report on Friday, December 13th. TD Cowen dropped their target price on Bruker from $72.00 to $70.00 and set a “hold” rating on the stock in a report on Wednesday, November 6th. The Goldman Sachs Group raised Bruker from a “sell” rating to a “neutral” rating and set a $60.00 target price on the stock in a report on Thursday, December 5th. Finally, Wells Fargo & Company dropped their target price on Bruker from $78.00 to $75.00 and set an “overweight” rating on the stock in a report on Wednesday, November 6th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Bruker presently has an average rating of “Moderate Buy” and an average target price of $70.50.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.